Loading...
01/11 05:01
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call indicates strong revenue growth, especially in key manufacturing programs, and an optimistic outlook for fiscal 2026 with improved gross margins and positive adjusted EBITDA. The Q&A section did not reveal significant negative trends, and the company's strategic expansion into defense aerospace alongside medical devices suggests diversification and potential profitability. Despite some concerns over gross margins and delayed orders, the overall sentiment is positive, supported by strong revenue expectations and strategic operational investments.
Quarterly Revenue $6.7 million, a 46% increase year-over-year (net of tariff reimbursements). The increase was driven by two key manufacturing programs: one with a top-tier aerospace company and another with a surgical robotics company for a single-use cystoscope.
Aerospace Program Revenue $2.5 million (net of tariffs), an increase of more than 800% year-over-year. Growth was supported by a $9 million backlog and increased production throughput due to a recent line expansion.
Cystoscope Program Revenue $1.5 million (net of tariffs), an 85% increase compared to the previous quarter and a 180% increase year-over-year. Growth was attributed to strong end-market demand and resolution of prior production issues.
Ross Optical Division Revenue Over $1 million, a 10% quarter-over-quarter increase. Growth was supported by existing staff and infrastructure, indicating a potential recovery in the optical components market.
Gross Margins 14.4%, compared to 12.9% in the prior quarter and 26.6% a year ago. Margins were impacted by under-absorption of engineering resources and delays in receiving a large defense customer reorder.
Product Development Revenue $656,000, the lowest in many years, due to the transition of programs from development to production. Recovery is expected with a 50%-75% quarter-over-quarter increase in Q2.
Operating Expenses (OpEx) $2.5 million, compared to $2.4 million a year ago. SG&A expenses increased due to one-time items like $184,000 in employee severance and higher stock-based compensation.
Adjusted EBITDA Negative $1.2 million, compared to negative $1.0 million a year ago. The decline was due to lower gross margins and higher operating expenses.
Augmented reality systems for defense applications: Signed a new development agreement for augmented reality systems, broadening exposure to aerospace and defense industries.
High-resolution borescope for jet engine inspection: Signed a new development agreement for a borescope with high-resolution capabilities for jet engine inspection, targeting aerospace industry.
Aerospace program: Achieved record quarterly revenue of $2.5 million (net of tariffs), an 800% increase year-over-year, with a backlog of over $9 million.
Single-use cystoscope program: Revenue increased to $1.5 million (net of tariffs), an 85% increase quarter-over-quarter and 180% year-over-year, driven by strong end-market demand.
Production infrastructure improvements: Expanded production line for aerospace program, increasing throughput by 50%. Enhanced cystoscope production systems to improve yield and efficiency.
Gross margin improvements: Negotiated tariff reimbursements and pricing adjustments for key programs, leading to improved gross margins.
Sales and marketing enhancements: Implemented new marketing strategies, including social media, webinars, and AI tools, resulting in new high-probability leads.
Transition to scaled production: Focused on scaling production capabilities to handle higher volumes, ensuring long-term operational efficiency and profitability.
Gross Margin Challenges: The company is facing gross margin challenges due to the aggressive ramp-up of production operations. This includes the need to build infrastructure, processes, and talent to scale, which has stressed the organization and increased costs.
Production Scaling Issues: The transition to higher production volumes has been challenging, requiring significant changes in team, infrastructure, and processes. The company underestimated the extent of these changes, which has impacted efficiency and margins.
Under-Absorption of Resources: The micro-optics and product development divisions suffered from under-absorption of resources due to unusually low revenue in the first quarter, negatively impacting margins.
Delayed Customer Orders: A significant reorder from a major defense contractor for the micro-optics division has been delayed, causing revenue and margin shortfalls.
Tariff Costs: Tariffs on sourced components have added costs, although some customers have agreed to reimburse these on a pass-through basis.
Dependence on Key Programs: The company’s financial performance is heavily reliant on a few key programs, such as the aerospace and cystoscope programs. Any disruption in these programs could significantly impact revenue.
Operational Growing Pains: The company is experiencing growing pains as it transitions to higher production volumes, including the need for updated systems and processes to handle increased demand.
Economic and Market Uncertainties: The optical components market has been impacted by tariffs and other uncertainties, leading to delayed customer orders and cautious spending.
Revenue Expectations: Precision Optics expects fiscal year 2026 revenue to exceed $25 million, supported by record revenue levels in systems manufacturing and a growing product development pipeline.
Adjusted EBITDA: The company anticipates approximately $0.5 million of positive adjusted EBITDA for fiscal year 2026, despite a first-quarter loss.
Aerospace Program Growth: Revenue for the aerospace program is expected to continue growing through fiscal 2026, supported by a $9 million backlog and a recent production line expansion increasing throughput by 50%.
Cystoscope Program Margins: Margins for the single-use cystoscope program are expected to improve quarter-over-quarter throughout fiscal 2026 due to production efficiency gains, pricing updates, and tariff reimbursements.
Product Development Pipeline: The product development division is expected to recover, with a 50%-75% quarter-over-quarter revenue increase in Q2 and additional growth in Q3 and Q4. New programs include augmented reality systems for defense and high-resolution borescopes for jet engine inspection.
Micro-Optics Division: Revenue and margins for the Micro-Optics division are expected to improve in Q2, driven by a delayed defense contract order and increased resource utilization.
Ross Optical Division: The Ross Optical division is cautiously optimistic about a recovery in the optical components market, with strong backlog and consecutive quarter-over-quarter revenue increases.
Operational Improvements: The company expects ongoing improvements in production efficiency and gross margins across major programs, contributing to profitability in fiscal 2026 and beyond.
Dividends: These improvements will pay dividends as more programs transfer to production, and we continue to ramp this part of the business into the future. This development of a scaled production capability should, over time, be value creating for shareholders.
The earnings call indicates strong revenue growth, especially in key manufacturing programs, and an optimistic outlook for fiscal 2026 with improved gross margins and positive adjusted EBITDA. The Q&A section did not reveal significant negative trends, and the company's strategic expansion into defense aerospace alongside medical devices suggests diversification and potential profitability. Despite some concerns over gross margins and delayed orders, the overall sentiment is positive, supported by strong revenue expectations and strategic operational investments.
The earnings call reveals record-high quarterly revenue and a significant increase in production revenue, despite a decline in gross margin. The Q&A section confirms conservative but optimistic guidance, with expectations of improved gross margins and a well-prepared pipeline. Management's clear responses and strategic focus on production and engineering projects suggest a positive outlook. The stock price is likely to react positively, with potential gains of 2% to 8% over the next two weeks.
The earnings call reflects significant challenges: a steep decline in gross margins, increased net losses, and staffing issues. The Q&A highlighted uncertainties about engineering revenue and production delays, although management expressed optimism about resolving these issues. Despite a $5 million raise to improve financial health, there's no immediate shareholder return plan. The military program's continuity is positive, but overall, the financial performance and lack of clear guidance on key issues suggest a negative sentiment. The market is likely to react negatively, with a potential stock price decrease between -2% and -8%.
The earnings call reveals a challenging financial situation with declining revenue, gross margin, and increased net loss. Despite a positive backlog and future purchase commitments, the weak financial performance and negative adjusted EBITDA are concerning. The Q&A highlights unresolved issues like tariffs and production delays, although management remains optimistic about future growth. However, the lack of clear guidance on key developments and ongoing expenses further clouds the outlook, suggesting a negative stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
